Matches in Wikidata for { <http://www.wikidata.org/entity/Q91511009> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- Q91511009 description "article scientifique publié en 2019" @default.
- Q91511009 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91511009 description "scientific article published on 25 November 2019" @default.
- Q91511009 description "wetenschappelijk artikel" @default.
- Q91511009 description "наукова стаття, опублікована 25 листопада 2019" @default.
- Q91511009 name "Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC" @default.
- Q91511009 name "Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC" @default.
- Q91511009 type Item @default.
- Q91511009 label "Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC" @default.
- Q91511009 label "Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC" @default.
- Q91511009 prefLabel "Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC" @default.
- Q91511009 prefLabel "Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC" @default.
- Q91511009 P1433 Q91511009-82AE674E-0FCB-4254-8F9C-B3D60CC6553F @default.
- Q91511009 P1476 Q91511009-74057D30-8AB8-4ACE-90B6-0ACA2CBBEAF6 @default.
- Q91511009 P2093 Q91511009-099052D2-02E7-476F-9B67-C9C9B8CD73E2 @default.
- Q91511009 P2093 Q91511009-1FDF36BB-238B-4F25-9BF2-638EC76812DF @default.
- Q91511009 P2093 Q91511009-25881726-AF4A-4D27-A527-89DC377ECC64 @default.
- Q91511009 P2093 Q91511009-44342B7C-9AA3-45A8-A03B-6232AC08DEEC @default.
- Q91511009 P2093 Q91511009-4EBB015C-206B-4E9E-A940-BFB3356EBE4A @default.
- Q91511009 P2093 Q91511009-5AF529BA-F095-4E3A-B131-8D1C04285459 @default.
- Q91511009 P2093 Q91511009-62AE4881-CCFB-4F3E-8903-AB79543D3399 @default.
- Q91511009 P2093 Q91511009-6D7A86B0-CFBB-4C7A-AE80-D98C6DBCF24A @default.
- Q91511009 P2093 Q91511009-72069675-9F3C-4FFF-90F5-0E3CDCBFD350 @default.
- Q91511009 P2093 Q91511009-7C8912C2-C8F8-497B-AEA3-4351E38B2684 @default.
- Q91511009 P2093 Q91511009-807875FD-D29D-4C6E-8F62-8BC47DBA76EA @default.
- Q91511009 P2093 Q91511009-9B80A675-24DB-43F1-9255-2CDDCEFD4B09 @default.
- Q91511009 P2093 Q91511009-AAA85C07-EDD7-4E22-B9B3-6B5C5CA1D709 @default.
- Q91511009 P2093 Q91511009-B55BB638-7210-4180-A8A6-899E585D9DDB @default.
- Q91511009 P2093 Q91511009-BF4DF0DD-826D-4C4B-9B36-02B566B8FD49 @default.
- Q91511009 P2093 Q91511009-C86F6D3C-547E-4B39-A5E1-DDBBFDCFAD43 @default.
- Q91511009 P2093 Q91511009-CA74972D-F3B0-407C-8A86-AF265903AC4A @default.
- Q91511009 P2093 Q91511009-D8D60584-174A-4740-AEDA-A8DA431EC93C @default.
- Q91511009 P2093 Q91511009-E8A58962-AB4A-4F27-8139-9318AAA8164F @default.
- Q91511009 P2093 Q91511009-FBAFB88D-DDC9-4C91-B45E-C2F86A295B77 @default.
- Q91511009 P304 Q91511009-3BAFA489-ED22-4170-A858-EA84419E356B @default.
- Q91511009 P31 Q91511009-B5A13CF3-079D-4FE0-9756-E95F56B6994B @default.
- Q91511009 P356 Q91511009-12DB1CA5-1ED0-45A7-9BDD-544738878DC3 @default.
- Q91511009 P433 Q91511009-E7270DB6-8A39-46D9-B0F3-DAFB56E1BADF @default.
- Q91511009 P478 Q91511009-AF4894D3-290B-4AC8-9190-B5AAC66F177F @default.
- Q91511009 P50 Q91511009-675D9C7E-C0D9-4E57-89B8-FA30F0AD08A9 @default.
- Q91511009 P50 Q91511009-B0B1C57C-E153-47B1-AF53-B19BE955EDB4 @default.
- Q91511009 P50 Q91511009-E4F56299-0EF3-4E2E-9E37-590317555D59 @default.
- Q91511009 P577 Q91511009-144B51C0-708E-42E8-8105-56CF0A725394 @default.
- Q91511009 P698 Q91511009-944DEC30-001C-460B-B490-D835003C264E @default.
- Q91511009 P921 Q91511009-396ADAC9-459A-4F07-A048-321D23D03520 @default.
- Q91511009 P921 Q91511009-AA6EFD51-814F-4327-9330-F8AB14256FE4 @default.
- Q91511009 P356 J.JTHO.2019.10.024 @default.
- Q91511009 P698 31778797 @default.
- Q91511009 P1433 Q2448056 @default.
- Q91511009 P1476 "Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC" @default.
- Q91511009 P2093 "Anne S Tsao" @default.
- Q91511009 P2093 "Brett W Carter" @default.
- Q91511009 P2093 "Charles Lu" @default.
- Q91511009 P2093 "Daniel R Gomez" @default.
- Q91511009 P2093 "Don L Gibbons" @default.
- Q91511009 P2093 "Ferdinandos Skoulidis" @default.
- Q91511009 P2093 "George Simon" @default.
- Q91511009 P2093 "Joe Y Chang" @default.
- Q91511009 P2093 "Jonathan M Kurie" @default.
- Q91511009 P2093 "Lauren A Byers" @default.
- Q91511009 P2093 "Luyang Yao" @default.
- Q91511009 P2093 "Mehmet Altan" @default.
- Q91511009 P2093 "Melenda D Jeter" @default.
- Q91511009 P2093 "Michael O'Reilly" @default.
- Q91511009 P2093 "Neda Kalhor" @default.
- Q91511009 P2093 "Peter Thall" @default.
- Q91511009 P2093 "Steven H Lin" @default.
- Q91511009 P2093 "Vali Papadimitrakopoulou" @default.
- Q91511009 P2093 "Yan Lin" @default.
- Q91511009 P2093 "Zhongxing Liao" @default.
- Q91511009 P304 "248-257" @default.
- Q91511009 P31 Q13442814 @default.
- Q91511009 P356 "10.1016/J.JTHO.2019.10.024" @default.
- Q91511009 P433 "2" @default.
- Q91511009 P478 "15" @default.
- Q91511009 P50 Q88721314 @default.
- Q91511009 P50 Q94702986 @default.
- Q91511009 P50 Q94703174 @default.
- Q91511009 P577 "2019-11-25T00:00:00Z" @default.
- Q91511009 P698 "31778797" @default.
- Q91511009 P921 Q3658562 @default.
- Q91511009 P921 Q42824440 @default.